SCHEMBL9378752

SCHEMBL9378752

O=C1CCc2cc(Cl)cc(Cl)c2N1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.52
CYP11B2 P19099 4/20 0.52
CYP1A2 P05177 1/20 0.52
SRD5A1 P18405 2/20 0.45
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CES1 P23141 2/20 0.43
DNMT1 P26358 1/20 0.43
AHR P35869 3/20 0.42
PDE7A Q13946 1/20 0.38
NPC1 O15118 1/20 0.37
MAPK13 O15264 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37
MAPK14 Q16539 1/20 0.37
CYP19A1 P11511 3/20 0.37
CRBN Q96SW2 1/20 0.37
CA9 Q16790 1/20 0.37
METAP2 P50579 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL428384 0.83 CYP11B1 (0.51) CYP11B1CYP11B2CYP1A2SRD5A1AHR
SCHEMBL25066324 0.82 AHR (0.56) CYP11B1CYP11B2CYP1A2MEN1KMT2A
SCHEMBL7278086 0.81 CYP11B1 (0.50) CYP11B1CYP11B2CYP1A2SRD5A1AHR
SCHEMBL8553375 0.81 CYP11B1 (0.50) CYP11B1CYP11B2CYP1A2SRD5A1MEN1
SCHEMBL14779528 0.81 CYP11B1 (0.50) CYP11B1CYP11B2CYP1A2SRD5A1AHR
SCHEMBL12559608 0.81 CYP11B1 (0.50) CYP11B1CYP11B2CYP1A2SRD5A1AHR
SCHEMBL19737432 0.78 CYP11B1 (0.47) CYP11B1CYP11B2CYP1A2SRD5A1MEN1
SCHEMBL8557681 0.78 CYP1A2 (0.47) CYP11B1CYP11B2CYP1A2SRD5A1AHR
SCHEMBL15828561 0.78 CYP11B1 (0.47) CYP11B1CYP11B2CYP1A2SRD5A1AHR
SCHEMBL7267699 0.76 CYP11B1 (0.46) CYP11B1CYP11B2CYP1A2SRD5A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0320992-B1 Triazolodiazepine derivatives HOFFMANN LA ROCHE (CH) 1994-07-27 EP disclosed
EP-0320992-A2 Triazolodiazepine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1989-06-21 EP disclosed